Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.0%

77 terminated/withdrawn out of 962 trials

Success Rate

87.3%

+0.8% vs industry average

Late-Stage Pipeline

6%

58 trials in Phase 3/4

Results Transparency

3%

18 of 527 completed trials have results

Key Signals

147 recruiting18 with results63 terminated14 withdrawn

Enrollment Performance

Analytics

N/A
407(70.1%)
Phase 2
74(12.7%)
Phase 1
40(6.9%)
Phase 3
40(6.9%)
Phase 4
18(3.1%)
Early Phase 1
2(0.3%)
581Total
N/A(407)
Phase 2(74)
Phase 1(40)
Phase 3(40)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (962)

Showing 20 of 962 trials
NCT02001649Not ApplicableCompleted

Genetic Variants Associated With Adolescent Suicide Attempts

Role: collaborator

NCT06681402Phase 1Active Not Recruiting

Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol

Role: lead

NCT06599931Not ApplicableRecruiting

Cerebello-motor Neuromodulation After Stroke. CERSTIM.

Role: lead

NCT04238871Terminated

RaDiCo PID Cohort (RaDiCo-ILD Cohort in English)

Role: lead

NCT05623150Recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Role: lead

NCT01802099Not ApplicableCompleted

Impact of Early Enteral vs. Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines

Role: collaborator

NCT06439199Recruiting

Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy

Role: collaborator

NCT06064825Recruiting

Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)

Role: lead

NCT01103206Phase 4Completed

Evaluation of a Cincalcet Suppression Test

Role: collaborator

NCT06245512Recruiting

Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood

Role: lead

NCT03078439Completed

EPIPAGE2 Cohort Study Follow up at Five and a Half Years

Role: lead

NCT05850273Recruiting

Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms

Role: lead

NCT06270095Completed

" Fume Events in Air Flights: Consequences on Cabin Air Quality and on Aircrews Health of a French Fleet of Aircraft"

Role: lead

NCT03256422Phase 3Completed

Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients

Role: collaborator

NCT05054361Recruiting

Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children

Role: lead

NCT06959212Not ApplicableRecruiting

Investigation of Mnesic Capacities in Patients With a Disorder of Consciousness

Role: collaborator

NCT06570278Not ApplicableRecruiting

Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes

Role: lead

NCT04919434Not ApplicableActive Not Recruiting

Intervention to Reduce Exposure to Environmental COntaminant (IRECO)

Role: lead

NCT06020651Not ApplicableCompleted

Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside

Role: collaborator

NCT01638949Not ApplicableCompleted

Multi-modal Neuroimaging in Alzheimer's Disease IMAP+

Role: collaborator